Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jackson Eye is a premier ophthalmology practice and clinical research center based in Lake Villa, Illinois. Founded by Dr. Mitchell Jackson, the center specializes in advanced cataract and refractive surgery, including LASIK and premium intraocular lens (IOL) implantation. The organization is highly active in the life sciences sector as a dedicated site for Phase 1 through Phase 4 clinical trials, collaborating with major pharmaceutical and medical device companies to evaluate novel treatments for conditions such as dry eye, glaucoma, and presbyopia. In April 2021, Jackson Eye was acquired by Unifeye Network, a practice management platform backed by Waud Capital Partners. The facility is recognized for its early adoption of innovative ophthalmic technologies and its significant contribution to the FDA approval processes for various eye care products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jackson Eye.